Creative Biolabs is highly specialized in advanced antibody biochemistry and engineering. With more than a decade of exploration and expansion, our current research and service capacity covers the entire new drug discovery and development pipeline, ranging from early discovery, pre-clinical evaluations, cGMP manufacturing, to clinical trials. Anti-CD22 (clone 10F4)-SMCC-DM1 ADC https://www.creative-biolabs.c....om/adc/mu10f4-smcc-d

Anti-CD22 (clone 10F4)-SMCC-DM1 ADC - Creative Biolabs

This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4) conjugated via a SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within